GTCR Invests $300M Into New Life Sciences Acquisition Co.
Private equity firm GTCR on Tuesday said it's partnering with two former executives of molecular diagnostics company Gen-Probe to form a new San Diego life sciences acquisition company, with GTCR investing...To view the full article, register now.
Already a subscriber? Click here to view full article